Related references
Note: Only part of the references are listed.Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation
Thomas L. Lynch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
MECHANISTIC PATHWAYS OF SEX DIFFERENCES IN CARDIOVASCULAR DISEASE
Vera Regitz-Zagrosek et al.
PHYSIOLOGICAL REVIEWS (2017)
Effects of myosin variants on interacting heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
Lorenzo Alamo et al.
ELIFE (2017)
Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice
Chen-Ching Yuan et al.
CARDIOVASCULAR RESEARCH (2017)
Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy The Past, Present, and Future
Brian P. Halliday et al.
CIRCULATION (2017)
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology
Perry Elliott et al.
EUROPEAN HEART JOURNAL (2016)
A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy
Jennifer Davis et al.
CELL (2016)
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
Yigal M. Pinto et al.
EUROPEAN HEART JOURNAL (2016)
Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain
Wenrui Huang et al.
FEBS JOURNAL (2015)
Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice
Chen-Ching Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Sex-dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload
Georgios Kararigas et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Experimental models of inherited cardiomyopathy and its therapeutics
Miki Nonaka et al.
WORLD JOURNAL OF CARDIOLOGY (2014)
Myosin Regulatory Light Chain (RLC) Phosphorylation Change as a Modulator of Cardiac Muscle Contraction in Disease
Christopher Toepfer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
Ray E. Hershberger et al.
NATURE REVIEWS CARDIOLOGY (2013)
Ventriculo-arterial decoupling in acutely altered hemodynamic states
Fabio Guarracino et al.
CRITICAL CARE (2013)
Animal Models of Heart Failure A Scientific Statement From the American Heart Association
Steven R. Houser et al.
CIRCULATION RESEARCH (2012)
Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease
Farah Sheikh et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Where Genome Meets Phenome: Rationale for Integrating Genetic and Protein Biomarkers in the Diagnosis and Management of Dilated Cardiomyopathy and Heart Failure
Sanaz Piran et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Fady I. Malik et al.
SCIENCE (2011)
Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development
Brett A. Colson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Ventricular–Vascular Interaction in Heart Failure
Barry A. Borlaug et al.
Heart Failure Clinics (2008)
Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation
Cheng-Kun Du et al.
CIRCULATION RESEARCH (2007)
Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity
Sudarsan Rajan et al.
CIRCULATION RESEARCH (2007)
Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function
Joachim P. Schmitt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations
Ying Wang et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
α-Myosin heavy chain -: A sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy
E Carniel et al.
CIRCULATION (2005)
Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca2+-dependent signaling cascade
J Lynch et al.
JOURNAL OF CELL BIOLOGY (2005)
A model for random sampling and estimation of relative protein abundance in shotgun proteomics
HB Liu et al.
ANALYTICAL CHEMISTRY (2004)
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
JP Schmitt et al.
SCIENCE (2003)
The effect of myosin light chain 2 dephosphorylation on Ca2+-sensitivity of force is enhanced in failing human hearts
J van der Velden et al.
CARDIOVASCULAR RESEARCH (2003)
Dilated cardiomyopathy: A disease of the intercalated disc?
JC Perriard et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
Share Paper
